Rua Bioscience is trading 8.33% up at NZD 0.04, with no clear catalyst identified.
- No company-specific announcement dated September 5–7, 2026, was identified.
- The latest material update, released August 27, reported 71% customer-revenue growth to $2.58 million, without explicitly linking the results to the share-price movement.
- Broader market indicators were flat.